Can-Fite Biopharma And Capital Point On Making Peace

About: Can-Fite BioPharma Ltd. (CANF)
by: First Genesis Consulting
This article is exclusive for subscribers.
First Genesis Consulting
Long/short equity, Deep Value, Growth, biotech

In the last 6 months, we watched the activist investor, Capital Point, launch a hostile takeover for Can-Fite Biopharma.

Detailed information on the legal fight via SEC filings made a good read as I discussed in two prior articles.

I ended my last article by noting that Capital Point and Can-Fite may need to work together to move this company forward.

In a recent SEC filing, Can-Fite reported a peace pact had been reached with Capital Point.


We started Q4/2019 with the news that Can-Fite Biopharma (CANF) had signed a “peace treaty” with the activist investor, Capital Point, that had initiated a potential hostile takeover 6 months prior. I